课题基金 / 基金详情

MECHANISMS FOR PITUITARY TUMORIGENESIS

MECHANISMS FOR PITUITARY TUMORIGENESIS
垂体肿瘤发生机制
批准号:
7023096
负责人:
SHLOMO MELMED
金额:
$27.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-15 至 2009-01-31

项目摘要

项目成果

SHLOMO MELMED的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pituitary adenomas are common benign neoplasms giving rise to disordered reproductive function, cortisol production, growth, thyroid homeostasis and local central pressure effects. Although determined to be monoclonal, the genetic mechanisms involved in pituitary cell transformation are as yet unresolved. This proposal will continue our work to characterize the properties of PTTG, a novel pituitary tumor-derived protein which has now been identified as the index mammalian securin. Securin regulates equal sister chromatid separation by inactivating separase activity during mitosis. Overexpressed PTTG causes chromosomal instability and aneuploidy. Human and rodent pituitary cells will be transfected with PTTG and degradation-deficient PTTG mutants and mitosis and chromosomal aneuploidy studied by live cell imaging. Transgenic mouse models of pituitary-driven PTTG overexpression (alphaGSU.PTTG) and of PTTG deletion (PTTG-/-) will be used to study the role of PTTG in the pathogenesis of pituicyte progression to hyperplasia and ultimately adenoma formation. The requirement of PTTG for pituitary hyperplasia during pregnancy, estrogen treatment and gonadectomy will be studied. MRI will be used to image transgenic murine pituitary growth in vivo. Effects of PTTG expression on pituitary cell proliferation, apoptosis and transformation will be assessed together with specific pituitary hormone gene expression. To gain further insight into pituitary tumorigenesis and PTTG interaction with other cell cycle regulators, these models will be cross-fertilized with other cell-cycle-disrupted transgenic mice known to develop spontaneous pituitary tumors. These studies will provide mechanistic insight into the role of chromosomal instability in the pathogenesis of pituitary tumors including prolactinomas, acromegaly, Cushing's disease and non-secreting alpha-subunit pituitary adenomas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ph 2 Multicenter study of seliciclib for Cushing Disease IND 120,848 (10/10/2017)
  • 批准号:
    10003845
  • 项目类别:
  • 资助金额:
    $46.78万
  • 财政年份:
    2018
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
Mechanisms for GH action on epithelial cells
  • 批准号:
    10578571
  • 项目类别:
  • 资助金额:
    $36.74万
  • 财政年份:
    2018
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
Mechanisms for GH action on epithelial cells
  • 批准号:
    9893867
  • 项目类别:
  • 资助金额:
    $38.25万
  • 财政年份:
    2018
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovit
  • 批准号:
    8773516
  • 项目类别:
  • 资助金额:
    $23.44万
  • 财政年份:
    2014
  • 负责人:
    SHLOMO MELMED
  • 依托单位:
国内基金
海外基金
RKTG对ERK信号通路的调控和肿瘤生成的影响